NCT01066494 - A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

January 31, 2011

Conditions

Acute Myeloid Leukemia

Interventions

DRUG

Amonafide + cytarabine

Amonafide 600 mg/m2 IV over 4 hours daily on days 1-5 in combination with cytarabine 200 mg/m2 IV continuous infusion (CI) daily on days 1-7

Trial Locations (6)

Vinnytsya Regional clinical Hospital, Vinnytsia

Institure of URgent adn Recovery Surgery n.a. V.K. gusaka of Academy Medical Science of Ukraine, Donetsk

Institute of Haematology and Transfusiology, Tbilisi

Medulla - Chemotherapy and Immunotherapy Clinic, Tbilisi

Hema - Haematology and Chemotherapy Clinic, Tbilisi

Kyiv bone Marrow Transplantation Centre, Kiev